126 related articles for article (PubMed ID: 7603526)
21. Fatal familial infantile glycogen storage disease: multisystem phosphofructokinase deficiency.
Amit R; Bashan N; Abarbanel JM; Shapira Y; Sofer S; Moses S
Muscle Nerve; 1992 Apr; 15(4):455-8. PubMed ID: 1533013
[TBL] [Abstract][Full Text] [Related]
22. Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions.
Nichols RC; Rudolphi O; Ek B; Exelbert R; Plotz PH; Raben N
Am J Hum Genet; 1996 Jul; 59(1):59-65. PubMed ID: 8659544
[TBL] [Abstract][Full Text] [Related]
23. Metabolic myopathy in canine muscle-type phosphofructokinase deficiency.
Giger U; Argov Z; Schnall M; Bank WJ; Chance B
Muscle Nerve; 1988 Dec; 11(12):1260-5. PubMed ID: 2976895
[TBL] [Abstract][Full Text] [Related]
24. Altered allosteric regulation of muscle 6-phosphofructokinase causes Tarui disease.
Brüser A; Kirchberger J; Schöneberg T
Biochem Biophys Res Commun; 2012 Oct; 427(1):133-7. PubMed ID: 22995305
[TBL] [Abstract][Full Text] [Related]
25. Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy.
Hays AP; Hallett M; Delfs J; Morris J; Sotrel A; Shevchuk MM; DiMauro S
Neurology; 1981 Sep; 31(9):1077-86. PubMed ID: 6943439
[TBL] [Abstract][Full Text] [Related]
26. Muscle phosphofructokinase deficiency in a myopathic child with severe mental retardation and aplasia of cerebellar vermis.
Pastoris O; Dossena M; Vercesi L; Scelsi R; Torcetta F; Savasta S; Bianchi E
Childs Nerv Syst; 1992 Jun; 8(4):237-41. PubMed ID: 1394261
[TBL] [Abstract][Full Text] [Related]
27. Muscle phosphofructokinase deficiency: two cases with unusual polysaccharide accumulation and immunologically active enzyme protein.
Agamanolis DP; Askari AD; Di Mauro S; Hays A; Kumar K; Lipton M; Raynor A
Muscle Nerve; 1980; 3(6):456-67. PubMed ID: 6450324
[TBL] [Abstract][Full Text] [Related]
28. Phosphofructokinase deficiency (Tarui disease) associated with hepatic glucuronyltransferase deficiency (Gilbert's syndrome): a case and family study.
Fogelfeld L; Sarova-Pinchas I; Meytes D; Barash V; Brok-Simoni F; Feigl D
Isr J Med Sci; 1990 Jun; 26(6):328-33. PubMed ID: 2380035
[TBL] [Abstract][Full Text] [Related]
29. Kinetic properties of erythrocyte phosphofructokinase in patients with type VII glycogenosis from two families--close similarity to liver type phosphofructokinase.
Shimizu T; Kono N; Mineo I; Sumi S; Nonaka K; Tarui S; Koyama W
J Inherit Metab Dis; 1984; 7(3):107-11. PubMed ID: 6239061
[TBL] [Abstract][Full Text] [Related]
30. Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.
Raben N; Exelbert R; Spiegel R; Sherman JB; Nakajima H; Plotz P; Heinisch J
Am J Hum Genet; 1995 Jan; 56(1):131-41. PubMed ID: 7825568
[TBL] [Abstract][Full Text] [Related]
31. Isozymes of human phosphofructokinase: biochemical and genetic aspects.
Vora S
Isozymes Curr Top Biol Med Res; 1983; 11():3-23. PubMed ID: 6227585
[TBL] [Abstract][Full Text] [Related]
32. Fatal infantile form of muscle phosphofructokinase deficiency.
Servidei S; Bonilla E; Diedrich RG; Kornfeld M; Oates JD; Davidson M; Vora S; DiMauro S
Neurology; 1986 Nov; 36(11):1465-70. PubMed ID: 2945125
[TBL] [Abstract][Full Text] [Related]
33. Juvenile-onset permanent weakness in muscle phosphofructokinase deficiency.
Malfatti E; Birouk N; Romero NB; Piraud M; Petit FM; Hogrel JY; Laforêt P
J Neurol Sci; 2012 May; 316(1-2):173-7. PubMed ID: 22364848
[TBL] [Abstract][Full Text] [Related]
34. Myopathies Related to Glycogen Metabolism Disorders.
Tarnopolsky MA
Neurotherapeutics; 2018 Oct; 15(4):915-927. PubMed ID: 30397902
[TBL] [Abstract][Full Text] [Related]
35. Familial phosphofructokinase deficiency is associated with a disturbed calcium homeostasis in erythrocytes.
Ronquist G; Rudolphi O; Engström I; Waldenström A
J Intern Med; 2001 Jan; 249(1):85-95. PubMed ID: 11168788
[TBL] [Abstract][Full Text] [Related]
36. Tarui disease and distal glycogenoses: clinical and genetic update.
Toscano A; Musumeci O
Acta Myol; 2007 Oct; 26(2):105-7. PubMed ID: 18421897
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of canine muscle type phosphofructokinase deficiency.
Smith BF; Stedman H; Rajpurohit Y; Henthorn PS; Wolfe JH; Patterson DF; Giger U
J Biol Chem; 1996 Aug; 271(33):20070-4. PubMed ID: 8702726
[TBL] [Abstract][Full Text] [Related]
38. [Exercise-induced muscle pain due to phosphofrutokinase deficiency: Diagnostic contribution of metabolic explorations (exercise tests, 31P-nuclear magnetic resonance spectroscopy)].
Drouet A; Zagnoli F; Fassier T; Rannou F; Baverel F; Piraud M; Bahuau M; Petit F; Streichenberger N; Marcorelles P; Vital Durand D
Rev Neurol (Paris); 2013; 169(8-9):613-24. PubMed ID: 24011984
[TBL] [Abstract][Full Text] [Related]
39. Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency.
Tsujino S; Servidei S; Tonin P; Shanske S; Azan G; DiMauro S
Am J Hum Genet; 1994 May; 54(5):812-9. PubMed ID: 7513946
[TBL] [Abstract][Full Text] [Related]
40. Increased plasma uric acid after exercise in muscle phosphofructokinase deficiency.
Kono N; Mineo I; Shimizu T; Hara N; Yamada Y; Nonaka K; Tarui S
Neurology; 1986 Jan; 36(1):106-8. PubMed ID: 2934643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
